Skip to Main Content

Paper Details

CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clin Pharmacol Ther
123
2014
CYP2D6, CYP2D6 genotype, Tamoxifen, cytochrome P450 2D6, estrogen, estrogen receptor, estrogen receptor-positive breast cancer, patients, tamoxifen, women
Author NameAffiliation
Michael A ProvinceCenter for Genome Sciences and Systems Biology, Washington University School of Medicine
Matthew P GoetzMayo Clinic
Vera J SumanMayo Clinic
Christine B AmbrosoneRoswell Park Cancer Institute
Christine B AmbrosoneRoswell Park Cancer Institute
Peter A FaschingUniversity Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, David Geffen School of Medicine, University of California at Los Angeles
Roberta FerraldeschiUniversity of Manchester and Central Manchester University Hospitals NHS Foundation Trust
Li GongStanford University
Diether LambrechtsVesalius Research Center, Catholic University Leuven
Matthias SchwabUniversity Hospital Tuebingen
Anna H WuUniversity of California san francisco
Anna H WuUniversity of California san francisco
Elad Zivand Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Elad Zivand Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Veronica Clavijo JordanGeorgetown University
Veronica Clavijo JordanGeorgetown University
Yusuke NakamuraHuman Genome Center, Institute of Medical Science, The University of Tokyo
Russ B AltmanStanford University
Richard M WeinshilboumMayo Clinic
James N IngleMayo Clinic
Teri E KleinStanford University
  • 1 - 21

Datasets

Release 1.2